ASTRONAUTX
AstronauTx is a UCL spin-off, will develop medicines designed to reset the behaviour of astrocytes.
ASTRONAUTX
Industry:
Pharmaceutical
Founded:
2019-01-01
Address:
Reading, Reading, United Kingdom
Country:
United Kingdom
Total Employee:
1+
Status:
Active
Total Funding:
7.5 M GBP
Similar Organizations
Advaxis
Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.
Auris Medical
Auris Medical develops novel pharmaceutical therapies to prevent and treat severe inner ear disorders.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Synapse Medicine
Synapse Medicine offers a medication intelligence platform for healthcare professionals.
Versameb
Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.
Current Employees Featured
Investors List
UCL Technology Fund
UCL Technology Fund investment in Venture Round - AstronauTx
Dementia Discovery Fund
Dementia Discovery Fund investment in Venture Round - AstronauTx